Elior Group's Stock Soars 6.36%, Exceeding Its Bollinger Bands
On Wednesday, shares of the mass catering specialist were priced at €2.642, up 6.36% from the previous close. This rebound is part of a positive weekly trend of 8.28%, while the CAC 40 itself has increased by 3.97% during the session.
Today's surge pushed Elior Group's stock price to €2.642, surpassing the upper Bollinger Band limit set at €2.58. This breach indicates a potential technical overbuy signal, with the price representing 127% of the band. Concurrently, the RSI stands at 46, a still neutral level that does not reflect significant tension between buyers and sellers. The discrepancy between a band indicator signaling an upward excess and a moderate RSI reflects the abruptness of the intraday movement, following several weeks of decline: the stock was down 5.44% over three months before this session. The nearest resistance is at €2.83, while the identified support is at €2.37. The 50-day and 200-day moving averages, established at €2.65 and €2.67 respectively, remain slightly above the current price, indicating that the stock has not yet reclaimed these medium and long-term thresholds despite the magnitude of today's rebound.
Upcoming Key Date
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The next major event for Elior Group is scheduled for May 20, 2026, the date set for the publication of the half-year results for the fiscal year 2025-2026. This upcoming deadline, now six weeks away, could be a crucial catalyst for the stock's trajectory, which still shows a positive annual performance of 16.29%. The stock's beta, measured at 0.18, confirms a very limited sensitivity to general market fluctuations. Monthly volatility remains contained at 9.52, making this Wednesday's surge all the more notable in a context where the Paris market is experiencing a strong session. The SBF 120, of which Elior is a part, indeed gained 3.92% during the session. The annual results, scheduled for November 19, 2026, will mark the second financial milestone of the current fiscal year.
SectorServices aux entreprises · Groupes hôteliers›Services de distribution et de restauration
Context
Period
Period: 2024-2025
Guidance from the release
Ces résultats confirment la trajectoire que nous avons engagée : redressement solide, croissance maîtrisée et ambition durable.
Retour à la profitabilité et à la distribution de dividendes, amélioration de la marge d'EBITA ajusté portée par la Restauration Collective (notamment US et péninsule ibérique) et optimisation opérationnelle ; poursuite du désendettement.
Risks mentioned
Non-renouvellement volontaire de contrats (impact en Italie mentionné)
Moindre demande de prestations d'intérim en France affectant les Multiservices
Ratio de levier encore élevé malgré désendettement (objectif ~3,0x)
Concentration sur grands contrats (dépendance à des signatures majeures)
Opportunities identified
Acquisition de 70% de Health Food & Beverage Group pour renforcer la position en Asie
Grand contrat avec West Virginia University comme relais de croissance en Amérique du Nord
Renforcement du mix clients et gains commerciaux sélectifs (stades UK, éducation, santé)
Amélioration continue de la rentabilité opérationnelle et plan d'innovation SI
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.